Dianthus Therapeutics, Inc.
Biotechnology Research • New York City, New York, United States
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who aim to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases.
Reported headcount
127
Headcount reported in the resolved company record. It is independent of the number of profiles indexed by Super Carl.
Company record. Source date unavailable.
Observed active job postings
28
Active postings in the available job data. Postings may be duplicated or stale and are not a verified count of vacancies or hires.
Indexed job postings. Source date unavailable.
Reported annual revenue estimate
$2.6M
Annual revenue from the resolved company record; estimates may differ from filed accounts.
Company record. Source date unavailable. Estimate.
Reported total funding
.4B
Reported cumulative funding in the available company record; missing value does not mean no funding.
Company record. Source date unavailable.
Reported latest funding round
$719M
Reported amount of the latest funding round available in the company record.
Company record. Source date unavailable.
Calculated as of 2026-09-20. Source records may be older.